Quoin Pharmaceuticals (QNRX) Earnings Date & Reports

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

QNRX is expected to report earnings to fall 88.50% to -24 cents per share on November 09

Quoin Pharmaceuticals QNRX Stock Earnings Reports

Q3'23

Est.

$-0.25

Q2'23

Beat

by $0.69

Q1'23

Missed

by $3.81

Q4'22

Beat

by $0.10

Q3'22

Missed

by $9.93

The last earnings report on August 02 showed earnings per share of -213 cents, beating the estimate of -281 cents. With 207.31M shares outstanding, the current market capitalization sits at 6.02M.

View a ticker or compare two or three

Compare

QNRX